Literature DB >> 10496290

Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias.

V Pact, T Giduz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10496290     DOI： 10.1212/wnl.53.5.1154-a

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  17 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 2.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

Review 3.  Management of essential tremor.

Authors:  Theresa A Zesiewicz; Elmyra Encarnacion; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 4.  Present and future drug treatment for Parkinson's disease.

Authors:  A H V Schapira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

Review 5.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

Review 6.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.

Authors:  M Lagière; S Navailles; L Mignon; A Roumegous; M-F Chesselet; P De Deurwaerdère
Journal:  Exp Brain Res       Date:  2013-03-28       Impact factor: 1.972

8.  Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study.

Authors:  Davide Uccellini; G Grampa; I La Spina; D Nasuelli; I Neromante; L Politini; F Reverberi; D Porazzi; V Carli; G Camardese
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

9.  A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.

Authors:  Abdulkader Alam; Zoya Voronovich; Joseph A Carley
Journal:  Prim Care Companion CNS Disord       Date:  2013-10-10

Review 10.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.